Clinical trials
Immune Development clinical trials
Below are recruiting immune development clinical trials, each written for real people, not researchers. We’re tracking 23 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05266664Recruiting
Studying immune development in preterm and vaccinated full-term babies
This study looks at how babies’ immune systems develop in early life and how they respond to immunization. It compares preterm infants with full-term infants whose mothers received Tdap during pregnancy, to learn what protection and immune responses to expect.
BredaAges 1 day–2 months - NCT07033663Recruiting
Monoclonal antibody exposure during pregnancy and baby's immune system
This study looks at how monoclonal antibody treatments given during pregnancy affect a baby's immune system development. It compares babies whose mothers received these treatments throughout pregnancy, only in early pregnancy, or not at all.
Esplugues de Llobregat, BarcelonaAges Any age - NCT03331133Recruiting
Study of twins born in Guangzhou
This study focuses on twins who were born at Guangzhou Women and Children’s Medical Center. It aims to use pregnancy and baseline information to learn about twin outcomes and care, and it may help local doctors improve guidance for families in Guangzhou.
Guangzhou, GuangdongAges Up to 18 years - NCT03633162Recruiting
Study about maternal grandmothers’ effects on babies
This study looks at whether what maternal grandmothers know, do, or influence during a pregnancy is linked to outcomes for grandchildren. You may be included if your grandchild was born at the study hospital and key pregnancy details are available.
Guangzhou, GuangdongAges 36–100 - NCT03668327Recruiting
Study of babies born early in Guangzhou
This study follows babies who were born early (before 37 weeks) to learn more about health outcomes over time. It may help doctors better understand and support families after an early birth.
GuangzhouAges Up to 18 years - NCT04529889Recruiting
Study of gestational diabetes during pregnancy and child outcomes
This study follows pregnant people with gestational diabetes to see how it affects mothers and babies over time. The team may use this information to better understand risks and care for both you and your child.
Guangzhou, GuangdongAges Any age - NCT06926166Recruiting
Genes and germs in early life study
This study looks at how genes and tiny organisms in your body (microbiota) affect early childhood development. It involves storing blood and stool samples from you and your child to help researchers learn more.
GuangzhouAges Any age - NCT02526901Recruiting
Pregnancy cohort study for women in Guangzhou
This study follows pregnant women from early pregnancy to learn about pregnancy and child health. You may be asked to share health information so researchers can better understand outcomes for babies born in Guangzhou.
Guangzhou, GuangdongAges Any age - NCT06944067Recruiting
Genetic risk of immune response after blood transfusions in sickle cell disease
This study looks at whether certain genes make people with sickle cell disease more likely to develop an immune reaction to blood transfusions. It aims to help doctors predict transfusion risks and improve care.
Bethesda, MarylandAges 2–99 - NCT05134779Recruiting
Study aims to tailor cancer treatment to your biology
This study looks at how genes, the cancer environment, and your immune system interact to develop treatments that work better for people with breast cancer. It may help researchers learn why some treatments work for certain people and not others.
New York, New YorkAges 18–90 - NCT06631937Recruiting
How infant feeding affects gut health and immunity
This study looks at how different feeding methods (like breast milk or formula) affect the development of healthy bacteria in a baby's gut and their immune system. It may help us understand what helps babies stay healthy.
AarhusAges birth–4 weeks - NCT06092463Recruiting
Immune system study in newborn intestines
This study looks at how the immune system develops in the intestines of newborns, including those born early or with a blocked intestine (atresia). It may help doctors understand inflammation and improve care for sick babies.
CopenhagenAges Up to 1 year - NCT06283160Recruiting
Pancreatic fistula study after Whipple surgery
This study looks at people having planned Whipple surgery (a type of pancreas surgery) to understand why some develop a leak called a pancreatic fistula. Researchers will study your blood and immune system to find ways to predict and prevent this complication.
BesançonAges 18 years+ - NCT07490587RecruitingPhase 2
Probiotic study for healthy infant growth and allergy prevention
This trial tests a probiotic supplement (Bifidobacterium animalis subsp. lactis XLTG11) to see if it helps infants grow better and have fewer allergies. It is for healthy babies up to 3 years old who are at higher risk for allergies.
Pudong, Shanghai MunicipalityAges birth–3 years - NCT05318196Recruiting
Predict kidney disease risk and progression from patient data
This trial looks at ways to predict how kidney disease may develop, change, or cause complications using information from patients. It may help doctors identify people at higher risk and tailor care earlier.
ToulouseAges 18–99 - NCT05055908RecruitingPhase 3
Testing immune-therapy for lung cancer and predicting response
This trial studies how well immune checkpoint medicines (with or without chemotherapy) work for lung cancer, and looks for biomarkers—tests that may help predict who benefits. It may help you access a structured treatment plan and additional response testing.
Changsha, HunanAges 18 years+ - NCT07316465Recruiting
Tracking immune markers in newborns at risk for eczema
This study follows newborns for two years to see how their immune system develops, especially if they have a family history of eczema, asthma, or hay fever. Researchers want to learn if certain immune markers appear early in babies who later develop eczema.
Jette, Brussels CapitalAges 1 hour–2 years - NCT05923333Recruiting
Breastfed infants of HIV-exposed mothers get a probiotic
This study gives a specific probiotic (from B. infantis) to babies born without HIV to see if it can improve the baby’s early immune health. It focuses on babies who are HIV-exposed because their mother has HIV and plans to exclusively breastfeed for the first 6 months.
Cape TownAges birth–50 years - NCT05986539Recruiting
Infant feeding and health study
This trial looks at how early feeding (breastmilk or formula) affects an infant's immune system and health. Researchers will collect samples and health information from mothers and their babies over time.
Moscow, IdahoAges 18 years+ - NCT06718530Recruiting
Finding early markers for liver cancer in people with chronic liver disease
This study looks for substances in your blood and immune system that could help doctors find liver cancer earlier. It is for people with liver cancer caused by chronic liver problems like hepatitis C, cirrhosis, or scarring.
Aviano, PordenoneAges 18 years+ - NCT06950697Recruiting
Blood clot risk prediction for lung cancer patients on immunotherapy
This study builds a tool to predict blood clot risk in lung cancer patients receiving immune checkpoint inhibitors. Researchers will use your data to develop a more personalized risk assessment, which may help prevent dangerous clots during treatment.
Zhengzhou, HenanAges 18 years+ - NCT06932237Recruiting
Immune causes of long COVID brain symptoms in veterans
This study is for veterans who have long COVID with brain or nerve symptoms. It looks at how the immune system may be causing these ongoing symptoms.
Portland, OregonAges 18–80 - NCT04923958Recruiting
Testing new TB screening and diagnostic tests
This study tests rapid TB screening and lab-style diagnostic methods to see how well they find TB disease and TB that is resistant to rifampin (a key TB drug). It may help doctors diagnose TB faster and more accurately, especially in people at higher risk.
TbilisiAges 12 years+
Hear when a new Immune Development trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for immune development?
- Yes. Clin2 currently lists 23 recruiting immune development studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a immune development trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a immune development trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.